The venture arm of European chemical company invests in companies developing technologies that are of strategic interest. The fund is flexible regarding investment and partnerships; most investments are made in Series A rounds but both seed-stage opportunities and later-stage opportunities may be of interest. Initial investments typically range from $1-7 million, and the fund generally syndicates with other investors. The fund will consider opportunities globally. In addition to capital the fund is able to provide strategic guidance and technical expertise to its portfolio companies.
Within the life science sector, the fund is interested in excipients, custom manufacturing and formulation, medical device coatings, agrochemicals, plant biotech (particularly technology that increases crop yield such as GMOs), industrial biotech (including fermentation), and medical uses of nanotechnology (including nanotech mechanisms for drug delivery). Within the coatings subsector, the fund is particularly interested in coatings that can be applied to polymers/surface technologies developed by the funds parent company.
The fund generally invests in pre-revenue companies that have developed proof of concept data or a prototype, and which have filed for patents. The fund always request a board seat subsequent to investment.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment